Literature DB >> 7120877

[Pharmacokinetics of prednisolone in adrenal insufficiency ].

C von Papen, G Benker, K Hackenberg, D Reinwein.   

Abstract

Prednisolone was measured in serum and urine after oral and intravenous administration of prednisone and prednisolone in 16 patients with adrenal insufficiency and after bilateral adrenalectomy. Thus, the problem of cross-reactivity with endogenous steroids, the main factor disturbing the measurement of prednisolone, was completely eliminated. Prednisolone was detected by a simple competitive protein-binding radioassay. Distribution, elimination and other bioavailability parameters were calculated from the obtained data. No significant differences between serum levels were detected after oral administration of these drugs. Peak levels were reached after 2-3 h. After 5, 7.5 and 10 mg prednisone peak serum levels averaged 11.9 +/- 2.2, 15.9+/-3.4 and 21.5+/-5.9 microgram/dl, respectively. Prednisolone was still detectable 24 h after administration of 10 mg. The plasma half-time of approximately 5 1/2 h suggests that prednisolone is present in serum far about 2 days after application of higher doses. Since prednisolone interferes in most assays for cortisol, prednisone therapie has to be stopped at least 2 days before cortisol determinations. Urinary excretion was proportional to the applicated doses. The metabolic clearance rate of prednisolone was decreased (56.0+/-7.2 1/24 h/m2) in patients with adrenal insufficiency. This can be attributed to alterations in corticosteroid metabolism, probably due to an increased transcortin production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7120877     DOI: 10.1007/bf01716801

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.

Authors:  A W Meikle; J A Weed; F H Tyler
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

2.  The disappearance of 7-H-3-d-aldosterone in the plasma of normal subjects.

Authors:  J F TAIT; S A TAIT; B LITTLE; K R LAUMAS
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

3.  Non-chromatographic radiotransinassay for cortisol: application to human adult serum, umbilical cord serum, and amniotic fluid.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

4.  Radioimmunoassay for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  Steroids       Date:  1973-06       Impact factor: 2.668

5.  Detection of synthetic corticosteroid analogues by the competitive protein-binding radioassay.

Authors:  H G Morris; G DeRoche; C M Caro
Journal:  Steroids       Date:  1973-09       Impact factor: 2.668

6.  Kinetic studies of cortisol and synthetic corticosteroids in man.

Authors:  P J Fell
Journal:  Clin Endocrinol (Oxf)       Date:  1972-01       Impact factor: 3.478

7.  [Study of a protein binding method for the determination of plasma corticoids].

Authors:  J Köbberling
Journal:  Z Klin Chem Klin Biochem       Date:  1972-02

8.  Conversion of cortisone to cortisol and prednisone to prednisolone.

Authors:  J S Jenkins; P A Sampson
Journal:  Br Med J       Date:  1967-04-22

9.  [Cortisol substitution in adrenal insufficiency (author's transl)].

Authors:  H K Kley; H L Krüskemper
Journal:  Dtsch Med Wochenschr       Date:  1978-01-27       Impact factor: 0.628

10.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.